Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study)

Sergio Serrano-Villar, Laura Martín-Pedraza, Juan Tiraboschi, María Novella, Alfonso Cabello-Úbeda, Luis López-Cortés, Carmen Busca, Miguel Torralba, María José Crusells, Carmen Hidalgo-Tenorio, Vicente Estrada, Ana del Amo-de Palacios, Alberto Díaz de Santiago, María Fons-Contreras, Jesús Santos, Enrique Bernal, Marta Montero-Alonso, Jesús Troya, José Ramón Blanco, Joaquín Burgos, Marta de Miguel, Santiago Moreno

Open source

DOI: 10.1093/cid/ciaf565
Published: 2025-10-10
Container: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciaf565,
  title = {Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study)},
  author = {Sergio Serrano-Villar and Laura Martín-Pedraza and Juan Tiraboschi and María Novella and Alfonso Cabello-Úbeda and Luis López-Cortés and Carmen Busca and Miguel Torralba and María José Crusells and Carmen Hidalgo-Tenorio and Vicente Estrada and Ana del Amo-de Palacios and Alberto Díaz de Santiago and María Fons-Contreras and Jesús Santos and Enrique Bernal and Marta Montero-Alonso and Jesús Troya and José Ramón Blanco and Joaquín Burgos and Marta de Miguel and Santiago Moreno},
  year = {2025},
  journal = {Clinical Infectious Diseases},
  doi = {10.1093/cid/ciaf565},
  url = {https://doi.org/10.1093/cid/ciaf565}
}

RIS

TY  - JOUR
TI  - Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study)
AU  - Sergio Serrano-Villar
AU  - Laura Martín-Pedraza
AU  - Juan Tiraboschi
AU  - María Novella
AU  - Alfonso Cabello-Úbeda
AU  - Luis López-Cortés
AU  - Carmen Busca
AU  - Miguel Torralba
AU  - María José Crusells
AU  - Carmen Hidalgo-Tenorio
AU  - Vicente Estrada
AU  - Ana del Amo-de Palacios
AU  - Alberto Díaz de Santiago
AU  - María Fons-Contreras
AU  - Jesús Santos
AU  - Enrique Bernal
AU  - Marta Montero-Alonso
AU  - Jesús Troya
AU  - José Ramón Blanco
AU  - Joaquín Burgos
AU  - Marta de Miguel
AU  - Santiago Moreno
PY  - 2025
JO  - Clinical Infectious Diseases
DO  - 10.1093/cid/ciaf565
UR  - https://doi.org/10.1093/cid/ciaf565
ER  -

APA

Serrano-Villar, S., Martín-Pedraza, L., Tiraboschi, J., Novella, M., Cabello-Úbeda, A., López-Cortés, L., Busca, C., Torralba, M., Crusells, M. J., Hidalgo-Tenorio, C., Estrada, V., Palacios, A. D. A., Santiago, A. D. D., Fons-Contreras, M., Santos, J., Bernal, E., Montero-Alonso, M., Troya, J., Blanco, J. R., Burgos, J., Miguel, M. D., & Moreno, S. (2025). Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study). Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf565

Source records

crossref · retrieved 2026-09-26T12:51:30.976Z